A global suppressor motif for p53 cancer mutants

被引:71
作者
Baroni, TE
Wang, T
Qian, H
Dearth, LR
Truong, LN
Zeng, J
Denes, AE
Chen, SW
Brachmann, RK
机构
[1] Washington Univ, Sch Med, Dept Med, Div Oncol, St Louis, MO 63110 USA
[2] Univ Calif Irvine, Div Hematol Oncol, Dept Med, Irvine, CA 92697 USA
关键词
D O I
10.1073/pnas.0401162101
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The transcription factor and tumor suppressor protein p53 is frequently inactivated in human cancers. In many cases, p53 gene mutations result in high levels of inactive, full-length p53 protein with one amino acid change in the core domain that recognizes p53 DNA-binding sites. The ability to endow function to mutated p53 proteins would dramatically improve cancer therapy, because it would reactivate a central apoptotic pathway. By using genetic strategies and p53 assays in yeast and mammalian cells, we identified a global suppressor motif involving codons 235, 239, and 240. These intragenic suppressor mutations, either alone or in combination, restored function to 16 of 30 of the most common p53 cancer mutants tested. The 235-239-240 suppressor motif establishes that manipulation of a small region of the core domain is sufficient to activate a large number of p53 cancer mutants. Understanding the structural basis of the rescue mechanism will allow the pursuit of small compounds able to achieve a similar stabilization of p53 cancer mutants.
引用
收藏
页码:4930 / 4935
页数:6
相关论文
共 32 条
  • [1] The UMD-p53 database:: New mutations and analysis tools
    Béroud, C
    Soussi, T
    [J]. HUMAN MUTATION, 2003, 21 (03) : 176 - 181
  • [2] Dominant-negative p53 mutations selected in yeast hit cancer hot spots
    Brachmann, RK
    Vidal, M
    Boeke, JD
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (09) : 4091 - 4095
  • [3] Genetic selection of intragenic suppressor mutations that reverse the effect of common p53 cancer mutations
    Brachmann, RK
    Yu, KX
    Eby, Y
    Pavletich, NP
    Boeke, JD
    [J]. EMBO JOURNAL, 1998, 17 (07) : 1847 - 1859
  • [4] Quantitative analysis of residual folding and DNA binding in mutant p53 core domain: definition of mutant states for rescue in cancer therapy
    Bullock, AN
    Henckel, J
    Fersht, AR
    [J]. ONCOGENE, 2000, 19 (10) : 1245 - 1256
  • [5] Rescuing the function of mutant p53
    Bullock, AN
    Fersht, A
    [J]. NATURE REVIEWS CANCER, 2001, 1 (01) : 68 - 76
  • [6] Restoration of the tumor suppressor function to mutant p53 by a low-molecular-weight compound
    Bykov, VJN
    Issaeva, N
    Shilov, A
    Hultcrantz, M
    Pugacheva, E
    Chumakov, P
    Bergman, J
    Wiman, KG
    Selivanova, G
    [J]. NATURE MEDICINE, 2002, 8 (03) : 282 - 288
  • [7] CRYSTAL-STRUCTURE OF A P53 TUMOR-SUPPRESSOR DNA COMPLEX - UNDERSTANDING TUMORIGENIC MUTATIONS
    CHO, YJ
    GORINA, S
    JEFFREY, PD
    PAVLETICH, NP
    [J]. SCIENCE, 1994, 265 (5170) : 346 - 355
  • [8] WAF1, A POTENTIAL MEDIATOR OF P53 TUMOR SUPPRESSION
    ELDEIRY, WS
    TOKINO, T
    VELCULESCU, VE
    LEVY, DB
    PARSONS, R
    TRENT, JM
    LIN, D
    MERCER, WE
    KINZLER, KW
    VOGELSTEIN, B
    [J]. CELL, 1993, 75 (04) : 817 - 825
  • [9] Ferlay J., 2001, GLOBOCAN 2000 CANC I
  • [10] Pharmacological rescue of mutant p53 conformation and function
    Foster, BA
    Coffey, HA
    Morin, MJ
    Rastinejad, F
    [J]. SCIENCE, 1999, 286 (5449) : 2507 - 2510